Beyond Air(R) Announces LungFit(R) PH Receives Market Authorization in Australia
(NASDAQ:XAIR), GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that the LungFit(R) PH has received market authorization from the […]